Allurion Technologies (ALURW) Liabilities and Shareholders Equity (2022 - 2026)
Allurion Technologies posted quarterly Liabilities and Shareholders Equity of $14.0 million for Q1 2026, down 63.57% year-on-year from $38.4 million in Q1 2025, and down 11.27% on a QoQ basis from $15.8 million in Q4 2025.
Allurion Technologies (ALURW) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 63.57% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2026 stood at $76.1 million (down 54.84% YoY), and the FY2025 full-year result was $15.8 million, down 51.93% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $14.0 million, down from $15.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $120.7 million in Q3 2023 and bottomed at $14.0 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $46.6 million (2024), against an average of $46.2 million.
- The widest annual swing landed in 2023, when Liabilities and Shareholders Equity surged 39.6%; it then sank 64.22% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $51.4 million in 2022, then surged by 39.6% to $71.7 million in 2023, then slumped by 54.24% to $32.8 million in 2024, then sank by 51.93% to $15.8 million in 2025, then dropped by 11.27% to $14.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $14.0 million (Q1 2026), $15.8 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 15.77 Mn |
| Sep 30, 2025 | 18.14 Mn |
| Jun 30, 2025 | 28.17 Mn |
| Mar 31, 2025 | 38.41 Mn |
| Dec 31, 2024 | 32.81 Mn |
| Sep 30, 2024 | 50.70 Mn |
| Jun 30, 2024 | 46.55 Mn |
| Mar 31, 2024 | 59.99 Mn |
| Dec 31, 2023 | 71.71 Mn |
| Sep 30, 2023 | 120.69 Mn |
| Jun 30, 2023 | 52.15 Mn |
| Dec 31, 2022 | 51.37 Mn |